Anuncia Medical, Inc. ("Anuncia"), a pioneering company in CSF management and neurocritical care, has received Breakthrough ...
A new research study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children’s Hospital Los ...
InSysBio, one of the world's pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with ...
If you've been thinking about switching from coffee to green tea, read on to learn everything you need to know about green ...
Researchers have worked with global partners to identify and successfully implement an intervention package that has significantly improved the diagnosis and management of brain infections in ...
In a study of biomarkers in Alzheimer’s dementia, plasma p-tau217 had greater agreement with CSF and amyloid-PET biomarker ...
News-Medical.Net on MSN5d
Blood-brain barrier dysfunction and inflammation linked to Down syndrome Regression DisorderA new research study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children's Hospital Los Angeles, shows evidence of dysfunction of the blood-brain barrier and ...
Monopoint system enables rapid access to the venous systemResearch to be presented at SNIS Cerebral Venous and CSF Disorders SummitSAN MATEO, ...
C2N Diagnostics, LLC, a specialty diagnostics company, has received a $10 million investment from Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback